Study to Evaluate a New Method to Detect Residual Tumours During Surgery for Prostate Cancer Using Confocal Microscopy

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

21

Participants

Timeline

Start Date

May 15, 2024

Primary Completion Date

December 15, 2024

Study Completion Date

January 7, 2025

Conditions
Prostate Cancer
Interventions
DIAGNOSTIC_TEST

NeuroSAFE procedure

Frozen section analysis of the posterolateral surface of the prostate to guide nerve sparing decisions.

DIAGNOSTIC_TEST

LaserSAFE procedure

The LaserSAFE procedure is performed using an FCM called the Histolog® scanner developed by Samantree® which can be placed within the operating room. The Histolog® scanner produces digital images with high, micrometre-range resolution and enables the visualization of tissue microstructures down to the cellular level.

Trial Locations (1)

W1G 8PH

University College Hospital at Westmoreland Street, London

All Listed Sponsors
collaborator

University College London Hospitals

OTHER

lead

University College, London

OTHER

NCT06398470 - Study to Evaluate a New Method to Detect Residual Tumours During Surgery for Prostate Cancer Using Confocal Microscopy | Biotech Hunter | Biotech Hunter